Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ADHD [NASD]
Alcobra Ltd.
Index- P/E- EPS (ttm)-1.87 Insider Own46.31% Shs Outstand13.63M Perf Week-3.83%
Market Cap47.98M Forward P/E- EPS next Y-2.10 Insider Trans- Shs Float7.32M Perf Month-16.19%
Income-24.40M PEG- EPS next Q-0.56 Inst Own32.60% Short Float24.34% Perf Quarter-82.98%
Sales- P/S- EPS this Y-420.00% Inst Trans4.47% Short Ratio3.39 Perf Half Y-79.66%
Book/sh2.59 P/B1.36 EPS next Y4.50% ROA-62.60% Target Price20.00 Perf Year-77.85%
Cash/sh2.85 P/C1.23 EPS next 5Y- ROE-67.40% 52W Range3.12 - 25.44 Perf YTD-80.44%
Dividend- P/FCF- EPS past 5Y0.00% ROI- 52W High-86.16% Beta-
Dividend %- Quick Ratio8.30 Sales past 5Y- Gross Margin- 52W Low12.82% ATR0.31
Employees9 Current Ratio8.30 Sales Q/Q- Oper. Margin- RSI (14)24.92 Volatility8.35% 7.06%
OptionableYes Debt/Eq0.00 EPS Q/Q-280.00% Profit Margin- Rel Volume0.34 Prev Close3.37
ShortableYes LT Debt/Eq0.00 EarningsNov 03 Payout- Avg Volume525.90K Price3.52
Recom2.10 SMA20-1.18% SMA50-58.84% SMA200-78.33% Volume180,819 Change4.45%
Nov-18-14Reiterated ROTH Capital Buy $30 → $10
Oct-23-14Downgrade FBR Capital Outperform → Mkt Perform $22 → $4
Oct-07-14Upgrade WBB Securities Hold → Speculative Buy $18 → $9
Oct-07-14Upgrade FBR Capital Mkt Perform → Outperform $23 → $22
Oct-06-14Reiterated ROTH Capital Buy $40 → $30
Aug-27-14Initiated FBR Capital Mkt Perform $23
Jun-26-14Initiated WBB Securities Hold $18
Apr-17-14Initiated Canaccord Genuity Buy $24
Dec-04-13Initiated Stifel Buy $27
Oct-08-13Reiterated Aegis Capital Buy $30 → $40
Jul-08-13Initiated Aegis Capital Buy $30
Nov-21-14 06:28PM  Robbins Arroyo LLP: Alcobra Ltd. (ADHD) Misled Shareholders According to a Recently Filed Class Action GlobeNewswire
10:32AM  SHAREHOLDER ALERT: Investigation on Behalf of Alcobra, Ltd. Investors Announced by Law Offices of Howard G. Smith Business Wire
Nov-20-14 05:48PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Alcobra Ltd. (ADHD) to Contact the Firm Marketwired
Nov-19-14 05:07PM  SHAREHOLDER ALERT: Class Action Lawsuit Against Alcobra, Ltd. Filed By Glancy Binkow & Goldberg LLP Business Wire
Nov-17-14 05:19PM  Aegis Capital Downgrades Alcobra Following Q3 Results Benzinga -5.74%
07:00AM  Alcobra Announces Third Quarter Financial Results and Provides Corporate Update GlobeNewswire
Nov-14-14 02:10PM  Bruker Downgraded to Sell on Disappointing Q3 Outcome Zacks
08:13AM  Flamel Technologies (FLML) in Focus: Stock Rises 11% Zacks
Nov-11-14 05:44AM  Regulus Slumps: RGLS Falls 5.3% in Session Zacks
Nov-06-14 08:00AM  Alcobra Ltd. to Release Third Quarter 2014 Financial Results and Host Corporate Update Conference Call and Webcast on Monday, November 17 GlobeNewswire +6.32%
Nov-03-14 08:00AM  Alcobra Ltd. to Present at Investor Conferences in November GlobeNewswire
Oct-31-14 11:53AM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Securities Laws Violations by the Board of Directors of Alcobra Ltd. Business Wire
Oct-30-14 07:24AM  Synergy Pharmaceuticals, Inc. (SGYP) Surges: Stock Rises 10% Zacks
Oct-28-14 10:30AM  INVESTOR ALERT: Investigation on Behalf of Alcobra Ltd. Shareholders Announced by Glancy Binkow & Goldberg LLP Business Wire
08:28AM  Zacks Rank #1 Additions for Tuesday Zacks
Oct-27-14 05:19PM  Block & Leviton LLP Investigates Alcobra Ltd, Its Officers and Directors for Possible Violations of the Federal Securities Laws PR Newswire
Oct-23-14 02:43PM  Alcobra Pharma downgraded by FBR Capital Briefing.com -26.06%
01:27PM  Midday Losers From October 23: Yelp, Alcobra, Ultratech Benzinga
09:26AM  Alcobra Applies Revisionist History to ADHD Drug Study Analysis at TheStreet
07:25AM  Alcobra Announces Presentation of New Data From Phase III Adult ADHD Study at AACAP Annual Meeting GlobeNewswire
Oct-17-14 09:41AM  5 Stocks Under $10 Set to Soar at TheStreet
Oct-08-14 02:30PM  Alcobra Reveals ADHD Top-line Phase III Data, Shares Down Zacks
08:08AM  Strength Seen in Alcobra (ADHD): Stock Rises 6.4% Zacks
Oct-07-14 08:35AM  Top Analyst Upgrades and Downgrades: Apple, Alcobra, Deere, GT, J.C. Penney and More at 24/7 Wall St. +6.37%
Oct-06-14 03:10PM  Why Alcobra (ADHD) Stock Hit a One-Year Low Today at TheStreet -56.63%
01:06PM  Alcobra ADHD drug meets goals, after data excluded; stock tanks Reuters
11:50AM  Alcobra Loses Focus in ADHD Trial for FDA Approval at 24/7 Wall St.
10:08AM  Alcobra ADHD Drug Fails Key Study Except When Patients Removed From Analysis at TheStreet
09:44AM  Stocks to Watch: H-P, Becton Dickinson, CareFusion at The Wall Street Journal
08:46AM  US STOCKS-Small biotech stocks plummet in premarket Reuters
06:41AM  Alcobra (ADHD) Crumbles: Stock Falls by 7.4% Zacks
06:00AM  Alcobra Announces Topline Results From Phase III Study of MDX in Adult ADHD GlobeNewswire
Oct-01-14 06:20PM  Nasdaq stocks posting largest percentage decreases AP -14.18%
Sep-24-14 09:04AM  Why Alcobra Investors Are So Nervous About a Coming Drug Study at TheStreet
Sep-23-14 05:00PM  Assurant (AIZ) Upgraded to Buy on New CEO, Acquisition Zacks
Sep-19-14 04:21PM  Alcobra Announces Completion of All Patient Visits in Phase III Clinical Trial of MDX in Adult ADHD GlobeNewswire
Sep-18-14 08:10AM  Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher Zacks
Sep-05-14 08:00AM  Alcobra Ltd. to Present at the Aegis Healthcare & Technology Conference GlobeNewswire
06:41AM  Weakness Seen in Alcobra (ADHD): Stock Falls 6.6% Zacks
Sep-02-14 08:00AM  Alcobra Announces Enrollment of First Patient in Phase IIb Clinical Trial of MDX in Adolescents With ADHD GlobeNewswire
Aug-27-14 09:58AM  Why Alcobra (ADHD) Stock Is Declining Today at TheStreet
Aug-20-14 05:21PM  Alcobra Starts Patient Enrollment for Mid-Stage Study on MDX Zacks
Aug-19-14 08:00AM  Alcobra Announces Enrollment of First Patient in Phase IIb Clinical Trial of MDX in Fragile X Syndrome GlobeNewswire
Aug-11-14 08:30AM  Alcobra Ltd Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q2 2014 Alcobra Ltd Earnings Release - Time Not Supplied CCBN
07:00AM  Alcobra Announces Second Quarter Financial Results and Provides Corporate Update GlobeNewswire
Aug-08-14 08:41AM  Alcobra Releases New Neuroimaging Data Supporting Pro-Cognitive Effects of MDX GlobeNewswire
Aug-06-14 08:00AM  Alcobra Ltd. to Provide Corporate Overview at the Canaccord Genuity 34th Annual Growth Conference GlobeNewswire +6.92%
Aug-01-14 08:00AM  Alcobra Ltd. to Release Second Quarter 2014 Results and Host Investor Conference Call and Webcast on Monday, August 11 GlobeNewswire
Jul-17-14 08:12AM  Alcobra Discusses New Market Research and Updates on Recent Corporate Events at Investor Forum in New York City GlobeNewswire
Jul-14-14 08:00AM  Alcobra Completes Patient Recruitment in Phase III Clinical Trial of MDX in Adult ADHD GlobeNewswire
Jul-07-14 08:00AM  Alcobra to Host Investor Forum and Webcast on July 15 in New York City GlobeNewswire
Jul-03-14 09:04AM  5 Stocks Spiking on Unusual Volume at TheStreet
08:16AM  Alcobra (ADHD) Jumps: Stock Adds 5.9% in Session Zacks
Jul-02-14 07:19AM  Alcobra shares should be bought ahead of data, says Stifel theflyonthewall.com +5.85%
Jun-24-14 06:56AM  Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% Zacks
Jun-17-14 08:00AM  Alcobra Ltd. to Provide Corporate Overview at the JMP Securities Healthcare Conference GlobeNewswire
Jun-12-14 02:25AM  Alcobra Ltd. (ADHD) Jumps: Stock Rises 8.7% Zacks
Jun-09-14 08:00AM  Alcobra to Present at the American Society of Clinical Psychopharmacology Annual Meeting and the BIO International Convention GlobeNewswire
May-27-14 08:00AM  Alcobra Ltd. to Provide Corporate Overview at the Jefferies 2014 Global Healthcare Conference GlobeNewswire
May-23-14 08:00AM  Alcobra Ltd. to Present at the Gordon Research Conference on Fragile X and Autism-Related Disorders GlobeNewswire
May-15-14 01:33PM  Alcobra's (ADHD) CEO Yaron Daniely on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
07:30AM  Alcobra Announces First Quarter Financial Results and Corporate Update GlobeNewswire
May-12-14 08:22AM  Alcobra presents improved data for Metadoxine at theflyonthewall.com
08:00AM  Alcobra Ltd. Presents Evidence of Novel Mechanism of Action for Metadoxine Extended Release (MDX) in Cognitive Disorders at the Society of Biological Psychiatry Annual Meeting GlobeNewswire
May-08-14 12:22PM  Alcobra gets FDA approval for Phase IIb trial of MDX at theflyonthewall.com
12:20PM  Alcobra Announces FDA Clearance of Protocol for Phase IIb Study of Metadoxine Extended Release (MDX) in the Treatment of Fragile X Syndrome GlobeNewswire
08:00AM  Alcobra Ltd. to Provide Corporate Overview at Oppenheimer and BioMed Conferences GlobeNewswire
07:24AM  Society of Biological Psychiatry to hold scientific meeting at theflyonthewall.com
May-07-14 04:05PM  Alcobra Ltd. to Release First Quarter 2014 Results and Host Investor Conference Call on Thursday, May 15, 2014 GlobeNewswire
May-06-14 11:52AM  Alcobra Ltd. Poised To Gain Some Attention In ADHD Market at Seeking Alpha
May-05-14 08:00AM  Alcobra Ltd. Presents Positive Results From Phase IIb Study of Metadoxine Extended Release (MDX) in Adults With Predominantly Inattentive ADHD at APA Annual Meeting GlobeNewswire
May-01-14 08:00AM  Alcobra Issued New US Patent Covering Metadoxine Use for Cognitive Disorders GlobeNewswire
Apr-24-14 08:00AM  Alcobra Ltd. to Present New Data for Metadoxine Extended Release (MDX) at Upcoming Meetings GlobeNewswire
Apr-10-14 12:30PM  Alcobra Ltd. Submits Protocol to FDA for Phase IIb Clinical Study of Metadoxine Extended Release (MDX) in the Treatment of Fragile X Syndrome GlobeNewswire -5.21%
Apr-04-14 01:04PM  ALCOBRA LTD. Financials EDGAR Online Financials
08:31AM  Venture Capitalist Ran Nussbaum Brings Big Finance To Little Biotechs at Seeking Alpha
Mar-26-14 08:00AM  Alcobra Announces Shares Uplisted to NASDAQ Global Market GlobeNewswire
Mar-24-14 11:10AM  Pipeline Update from Alcobra Zacks
Mar-18-14 09:28AM  Todays Top Biotech Stories: Prosensa, Medivation, and Alcobra at Motley Fool
08:10AM  Alcobra announces enrollment of first patient in Phase 3 clinical trial for MDX at theflyonthewall.com
08:00AM  Alcobra Announces Enrollment of First Patient in Phase 3 Clinical Trial for MDX in Adult ADHD GlobeNewswire
Mar-07-14 05:40PM  Alcobra Gains IND Clearance for MDX Zacks
Mar-06-14 09:18AM  Alcobra announces FDA clearance of IND for MDX at theflyonthewall.com +7.07%
09:15AM  Alcobra Announces FDA Clearance of IND for Metadoxine Extended Release (MDX) GlobeNewswire
Feb-26-14 06:08AM  Alcobra (ADHD) Jumps: Stock Rises 8.5% Zacks
Feb-24-14 08:00AM  Alcobra Ltd. to Discuss Biomarkers in Fragile X and Autism Trials at the Second Annual Autism Investment Conference GlobeNewswire
Feb-19-14 05:19PM  CFO Moves: Alcobra, OpenX Technologies, Garmin at The Wall Street Journal
08:00AM  Alcobra Appoints J.P. Morgan Banker Dr. Tomer Berkovitz as Chief Financial Officer GlobeNewswire
Feb-17-14 12:47PM  Alcobra's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
Feb-13-14 06:08PM  U.S./Canada daily earnings hits & misses Feb 13 - 1800 ET Reuters
08:00AM  Alcobra Announces Fourth Quarter and Fiscal Year End 2013 Financial Results and Corporate Update GlobeNewswire
Feb-07-14 01:58PM  Alcobra Announces IND Submission for Extended Release Metadoxine to Treat Adults With ADHD GlobeNewswire +6.22%
Jan-31-14 08:00AM  Alcobra Ltd. to Provide Corporate Overview at 16th Annual BIO CEO & Investor Conference GlobeNewswire
Jan-29-14 08:00AM  Alcobra Ltd. to Release Fourth Quarter 2013 Results and Host Investor Conference Call on Thursday, February 13, 2014 GlobeNewswire
Jan-27-14 08:00AM  Alcobra Announces New Biomarker Finding in a Follow-Up Fragile X Animal Study for MG01CI GlobeNewswire
Jan-22-14 02:29AM  Alcobra (ADHD) Jumps: Stock Rises 9.0% Zacks
Jan-15-14 11:35AM  Alcobra's ADHD Program Moving To Pediatrics at Seeking Alpha
Jan-14-14 06:12PM  Six Israeli Biotech New Issues Set A Blistering Pace at Investor's Business Daily
Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary drug candidates. It offers most advanced product (MDX) for the treatment of attention deficit hyperactivity disorder (ADHD) and other cognitive dysfunctions, including Fragile X. The company has initiated a Phase III clinical trial in the United States for the use of MDX to treat ADHD in adults. Alcobra Ltd. was founded in 2008 and is headquartered in Tel Aviv, Israel.